JATT II Acquisition Corp. (JATT) Prices $60M IPO

JATT II Acquisition Corp. (NASDAQ:JATT) announced the pricing of its $60 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “JATT” on Friday, April 17, 2026.

The new SPAC intends to combine with a healthcare or healthcare-related business with an emphasis on biotechnology and broader life sciences.

JATT II is to be led by Chairman and Chief Executive Officer Dr. Someit Sidhu and Chief Financial Officer Nicholas Fernandez. Verender S. Badial, Christopher Staral, Dr. Arjun Goyal, and Dr. Jonathan Kluft will serve on its Board of Directors.

Total SPAC deal count for 2026 year-to-date is now 68. This offering is expected to close on Monday, April 20, 2026.

Guggenheim Securities, LLC is acting as sole book-running manager. Loeb & Loeb LLP is serving as Issuer’s Counsel with Davis Polk & Wardwell LLP serving as Underwriter’s Counsel. WithumSmith+Brown, PC serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.